PARP inhibitors in epithelial ovarian cancer: what are their potential implications for surgical management?

被引：2
|
作者：
Peters, Inge [1 ,2 ]
Marchetti, Claudia [1 ,2 ]
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Womans & Child Hlth & Publ Hlth Sci, Gynecol Oncol Unit, I-00168 Rome, RM, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
EJSO | 2023年 / 49卷 / 09期
关键词：
Epithelial ovarian cancer; PARP inhibitors; Surgical management; Progression-free survival; Postoperative morbidity; PRIMARY SURGERY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1016/j.ejso.2023.06.025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PARP inhibitors in the treatment of ovarian cancer
    Alain G. Zeimet
    Verena Wieser
    Katharina Knoll
    Daniel Reimer
    Christian Marth
    memo - Magazine of European Medical Oncology, 2020, 13 : 198 - 201
  • [42] Potential of osteopontin in the management of epithelial ovarian cancer
    Cerne, Katarina
    Hadzialjevic, Benjamin
    Skof, Erik
    Verdenik, Ivan
    Kobal, Borut
    RADIOLOGY AND ONCOLOGY, 2019, 53 (01) : 105 - 115
  • [43] PARP inhibitors as single agents and in combinations for ovarian cancer: What lies ahead?
    Matulonis, Ursula A.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 17 - 17
  • [44] Initial surgical management of advanced epithelial ovarian cancer
    Benjamin, I
    Rubin, SC
    CANCER INVESTIGATION, 1997, 15 (03) : 270 - 276
  • [45] SURGICAL MANAGEMENT OF OVARIAN EPITHELIAL CANCER IN EARLY STAGES
    Edderdabi, Z.
    Benjelloun, A. Touimi
    Benchrifi, Y.
    Benhessou, M.
    Ennachit, M.
    Elkarroumi, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A458 - A458
  • [46] PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective
    Loizzi, Vera
    Ranieri, Girolamo
    Laforgia, Mariarita
    Gadaleta, Cosmo Damiano
    Gargano, Giulio
    Kardhashi, Anila
    De Liso, Maria
    Naglieri, Emanuele
    Del Vecchio, Vittoria
    Cicinelli, Ettore
    Cormio, Gennaro
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [47] Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
    Jiang, Yifan
    Zhao, Juan
    Zhang, Li
    Tian, Sijuan
    Yang, Ting
    Wang, Li
    Zhao, Minyi
    Yang, Qing
    Wang, Yaohui
    Yang, Xiaofeng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Making the best of PARP inhibitors in ovarian cancer
    Susana Banerjee
    Stan B. Kaye
    Alan Ashworth
    Nature Reviews Clinical Oncology, 2010, 7 : 508 - 519
  • [49] The Current Landscape of PARP Inhibitors in Ovarian Cancer
    Gunderson, Camille C.
    Erickson, Britt K.
    Buechel, Megan E.
    Moore, Kathleen N.
    CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2018, 7 (01): : 20 - 27
  • [50] Making the best of PARP inhibitors in ovarian cancer
    Banerjee, Susana
    Kaye, Stan B.
    Ashworth, Alan
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (09) : 508 - 519
12345